Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,760 | 298 | 98.6% |
| Education | $97.53 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,499 | 89 | $0 (2024) |
| Janssen Biotech, Inc. | $1,049 | 45 | $0 (2024) |
| Lilly USA, LLC | $757.51 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $522.57 | 24 | $0 (2024) |
| PFIZER INC. | $414.75 | 15 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $386.68 | 12 | $0 (2024) |
| Amgen Inc. | $300.89 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $262.94 | 11 | $0 (2024) |
| LEO Pharma Inc. | $233.92 | 6 | $0 (2024) |
| Celgene Corporation | $222.98 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,861 | 134 | ABBVIE INC. ($513.57) |
| 2023 | $1,367 | 55 | ABBVIE INC. ($296.53) |
| 2022 | $1,120 | 59 | ABBVIE INC. ($306.90) |
| 2021 | $245.20 | 19 | AbbVie Inc. ($168.24) |
| 2020 | $67.07 | 4 | Lilly USA, LLC ($34.83) |
| 2019 | $237.53 | 15 | Janssen Biotech, Inc. ($84.93) |
| 2018 | $484.78 | 9 | Sun Pharmaceutical Industries Inc. ($137.94) |
| 2017 | $475.10 | 6 | AbbVie, Inc. ($170.89) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Dermatology | ||||||
| 11/16/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Inflammation & Immunology | ||||||
| 11/15/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $33.79 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $75.33 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Immunology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.32 | General |
| Category: Immunology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Immunology | ||||||
| 10/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,360 | 2,353 | $349,076 | $133,113 |
| 2022 | 22 | 1,895 | 3,394 | $481,722 | $183,514 |
| 2021 | 22 | 1,854 | 3,453 | $481,262 | $199,659 |
| 2020 | 20 | 1,161 | 2,072 | $285,378 | $106,883 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 210 | 304 | $60,468 | $30,989 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 325 | $48,930 | $20,979 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 145 | $33,165 | $13,378 | 40.3% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 22 | 90 | $20,700 | $10,307 | 49.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 51 | 71 | $21,900 | $10,120 | 46.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 122 | 134 | $27,000 | $8,182 | 30.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 183 | 228 | $34,650 | $7,842 | 22.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 116 | 186 | $35,908 | $6,011 | 16.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 16 | 16 | $7,280 | $4,903 | 67.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 17 | $12,600 | $4,829 | 38.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 124 | 672 | $13,620 | $3,986 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $9,540 | $3,304 | 34.6% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 15 | 15 | $4,500 | $2,030 | 45.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,752 | $1,739 | 46.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 31 | $2,945 | $1,433 | 48.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 13 | $8,260 | $1,379 | 16.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 26 | $3,120 | $1,328 | 42.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 17 | $738.00 | $372.18 | 50.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 237 | 350 | $65,538 | $35,520 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 319 | 443 | $66,900 | $30,263 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 219 | $49,275 | $22,484 | 45.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 250 | 342 | $51,900 | $12,472 | 24.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 174 | 193 | $39,000 | $11,445 | 29.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 52 | 75 | $23,100 | $11,095 | 48.0% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 15 | 80 | $18,400 | $9,502 | 51.6% |
About Whitney Fisk
Whitney Fisk is a Dermatology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1306194584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Whitney Fisk has received a total of $6,857 in payments from pharmaceutical and medical device companies, with $2,861 received in 2024. These payments were reported across 301 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($6,760).
As a Medicare-enrolled provider, Fisk has provided services to 6,270 Medicare beneficiaries, totaling 11,272 services with total Medicare billing of $623,169. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Sacramento, CA
- Active Since 08/21/2012
- Last Updated 10/01/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1306194584
Products in Payments
- TREMFYA (Drug) $930.89
- TALTZ (Drug) $667.25
- SKYRIZI (Biological) $602.23
- RINVOQ (Biological) $599.58
- Otezla (Drug) $473.87
- DUPIXENT (Biological) $344.65
- CIBINQO (Drug) $256.58
- COSENTYX (Biological) $256.11
- Sotyktu (Drug) $193.02
- OPZELURA (Drug) $184.83
- Humira (Biological) $170.89
- Bimzelx (Biological) $150.81
- ILUMYA (tildrakizumab-asmn) injection (Biological) $137.94
- Winlevi (Drug) $125.78
- COSENTYX (Drug) $123.91
- ILUMYA (Biological) $122.96
- ADBRY (Biological) $121.04
- ENSTILAR (Drug) $112.88
- LITFULO (Drug) $91.87
- OLUMIANT (Drug) $90.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Sacramento
Dr. Raja Sivamani, M.d., M.s., A.h.e, M.D., M.S., A.H.E
Dermatology — Payments: $1.3M
Dr. Emil Tanghetti, M.d, M.D
Dermatology — Payments: $1.0M
Jacqueline Calkin, M.d, M.D
Dermatology — Payments: $130,291
Dr. Emanual Maverakis, M.d, M.D
Dermatology — Payments: $52,284
Alison Boudreaux, M.d, M.D
Dermatology — Payments: $46,728
Mirza Alikhan, Md, MD
Dermatology — Payments: $30,111